Curcumin Allays Dichlorvos-Provoked Multi-Organ Dysfunction in Rats by Reversing Biochemical, Cytomembrane, and Histological Abnormalities

  • A. A. ADEBISI Lagos State University College of Medicine, Ikeja, Lagos State
  • B. A. OLAGUNJU Federal University of Agriculture, Abeokuta, Ogun State, Nigeria
  • N. M. AKAMO Federal University of Agriculture, Abeokuta, Ogun State, Nigeria
  • A. S. OYELAKIN Federal University of Agriculture, Abeokuta, Ogun State, Nigeria
  • O. F. AKINYEMI Federal University of Agriculture, Abeokuta, Ogun State, Nigeria
  • O. M. OLUMIDE Lagos State University College of Medicine, Ikeja, Lagos State
  • T. S. ADEKUNBI Lagos State University College of Medicine, Ikeja, Lagos State
  • A. O. OJELABI Federal University of Agriculture, Abeokuta, Ogun State, Nigeria
  • O. T. KAYODE Mountain Top University, Ibafo, Ogun State, Nigeria
  • O. O. AYODELE Mountain Top University, Ibafo, Ogun State, Nigeria
  • R. T. ONIKOLA State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China
  • A. J. AKAMO Federal University of Agriculture, Abeokuta, Ogun State, Nigeria
Keywords: Dichlorvos, Curcumin, Cytomembrane, Damage marker enzymes, Organophosphate pesticide, Visceral

Abstract

One of the most widely used organophosphorus (OP) insecticides and acaricides is
dichlorvos [O, O-dimethyl O-(2,2-dichlorovinyl) phosphate or DDVP].
Nevertheless, it endangers public health due to its presence in food/ items and
drinking water. Conversely, curcumin is known for its cytomembrane stabilizing
properties. Regardless, there is a dearth of information on its impact on
dichlorvos-mediated damage marker enzyme distortion. This study aimed to
evaluate the efficacy of curcumin in mitigating DDVP-mediated multi-organ
dysfunction, particularly biochemical, cytomembrane, and histological
abnormalities. We exposed rats to DDVP (20 mg/kg/day) and treated them with
curcumin (50 mg/kg/day and 100 mg/kg/day) or the reference drug, atropine (0.2
mg/kg/day). After one week of DDVP exposure and two weeks of curcumin
intervention, male rats were euthanized and sacrificed, thereafter, blood and
organs (liver, kidney, heart, lung, and brain) were collected. Curcumin therapy
significantly (p < 0.05) ameliorated DDVP-induced increase in plasma total
protein, albumin (plasma and liver), and direct bilirubin (liver and kidney). It also
markedly (p<0.05) abrogated DDVP-mediated reductions in total bilirubin levels
in the plasma, liver, and kidney while preserving activities of key enzymes creatine
kinase and acetylcholinesterase in the heart and brain. Additionally, curcumin
normalized levels of plasma, liver, and kidney creatinine, urea, uric acid, and
plasma, liver, kidney, heart, and lung enzymes (ALT, AST, ALP, LDH) disrupted
by DDVP exposure. Histoarchitectural assessment confirm that curcumin
mitigated DDVP-incited organ deterioration. These findings accentuate curcumin
therapeutic potential for mitigating DDVP-induced dysfunction on vital organs via
reversal of biochemical, cytomembrane, and histological anomalies.

Author Biographies

A. A. ADEBISI, Lagos State University College of Medicine, Ikeja, Lagos State

Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Lagos State University College
of Medicine, Ikeja, Lagos State, Nigeria.

B. A. OLAGUNJU, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Clinical Biochemistry and Mechanistic Toxicology Research
Cluster, Department of Biochemistry, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

N. M. AKAMO, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Department of Microbiology, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

A. S. OYELAKIN, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Department of Pure and Applied Botany, Federal University of Agriculture, Abeokuta, Ogun State,
Nigeria.

O. F. AKINYEMI, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Department of Pure and Applied Botany, Federal University of Agriculture, Abeokuta, Ogun State,
Nigeria

O. M. OLUMIDE, Lagos State University College of Medicine, Ikeja, Lagos State

Department of Physiology, Faculty of Basic Medical Sciences, Lagos State University College
of Medicine, Ikeja, Lagos State, Nigeria

T. S. ADEKUNBI, Lagos State University College of Medicine, Ikeja, Lagos State

1Department of Medical Biochemistry, Faculty of Basic Medical Sciences, Lagos State University College
of Medicine, Ikeja, Lagos State, Nigeria.

A. O. OJELABI, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Clinical Biochemistry and Mechanistic Toxicology Research
Cluster, Department of Biochemistry, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

O. T. KAYODE, Mountain Top University, Ibafo, Ogun State, Nigeria

Department of Biochemistry, Mountain Top University, Ibafo,
Ogun State, Nigeria

O. O. AYODELE, Mountain Top University, Ibafo, Ogun State, Nigeria

Department of Biochemistry, Mountain Top University, Ibafo,
Ogun State, Nigeria

R. T. ONIKOLA, State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China

Key Laboratory of Green Process and Engineering, State Key Laboratory of
Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing
100190, PR China

A. J. AKAMO, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Clinical Biochemistry and Mechanistic Toxicology Research
Cluster, Department of Biochemistry, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria

Published
Y-m-d